loading

Clearmind Medicine Inc Borsa (CMND) Ultime notizie

pulisher
Apr 01, 2025

Clearmind launches data system for alcohol addiction trial - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Clearmind Implements EDC System To Streamline Phase I/II Trial For Alcohol Use Disorder Drug - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

Clearmind Medicine launches EDC system to support Phase I/II trial - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Clearmind launches data system for alcohol addiction trial By Investing.com - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment - The Manila Times

Apr 01, 2025
pulisher
Mar 22, 2025

Psychedelic: Exclusive talk with biotech company Clearmind Medicine - Yahoo Finance

Mar 22, 2025
pulisher
Mar 21, 2025

Clearmind’s AUD drug candidate arrives in the U.S. for trials By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

Clearmind Medicine Moves Closer to CMND-100 Trial After Alcohol Use Disorder Drug Candidate Arrives in US - MarketScreener

Mar 21, 2025
pulisher
Mar 21, 2025

Clearmind’s AUD drug candidate arrives in the U.S. for trials - Investing.com

Mar 21, 2025
pulisher
Mar 21, 2025

Clearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones - The Manila Times

Mar 21, 2025
pulisher
Mar 21, 2025

Clearmind Medicine Inc. Announces Arrival of CMND-100 in the U.S. Ahead of Phase I/IIa Trial for Alcohol Use Disorder - Nasdaq

Mar 21, 2025
pulisher
Mar 21, 2025

Clearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones - TradingView

Mar 21, 2025
pulisher
Mar 19, 2025

Clearmind and Polyrizon partner on nasal drug delivery By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Clearmind Medicine To Develop Novel Intranasal Formulation With Polyrizon - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

Clearmind and Polyrizon partner on nasal drug delivery - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination - The Manila Times

Mar 19, 2025
pulisher
Mar 19, 2025

Clearmind begins phase I/IIa trial for AUD treatment - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Clearmind Medicine Advances CMND-100 To Clinical Trials For Alcohol Use Disorder - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Clearmind Medicine Initiates First Clinical Trial Of CMND-100 For Alcohol Use Disorder Treatment - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Clearmind begins phase I/IIa trial for AUD treatment By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Clearmind Begins Human Trials for Potential Psychedelic Treatment for Alcohol Abuse Patients - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

Clearmind Medicine Inc. Initiates Phase I/IIa Clinical Trial for CMND-100 in Alcohol Use Disorder Patients - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in ... - The Bakersfield Californian

Mar 18, 2025
pulisher
Mar 11, 2025

Clearmind Medicine (CMND) versus Its Peers Head to Head Contrast - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Clearmind secures South Korean patent for addiction therapy By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Bulls Turn to Pennies STSS, ADTX, CSDX, SPRC, CBDW, YGTFF During Market Uncertainty – Small-Cap Stocks Poised for Big Moves - Financial Content

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc Shares Are Soaring Monday: What's Going On? - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

Scisparc, Clearmind apply for patent in South Korea for its co-developed treatment to overcome cocaine addiction - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Clearmind secures South Korean patent for addiction therapy - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc announces publication of patent via Clearmind collaboration - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc Ltd. and Clearmind Medicine Inc. Announce Patent Application for Combination Treatment of Cocaine Addiction - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

SciSparc Advances Cocaine Treatment Patent Following Successful Preclinical Data - StockTitan

Mar 10, 2025
pulisher
Mar 10, 2025

Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea - The Manila Times

Mar 10, 2025
pulisher
Mar 10, 2025

Clearmind Medicine Announces Publication Of Patent For Cocaine Addiction Psychedelic Combination Treatment In South Korea - MENAFN.COM

Mar 10, 2025
pulisher
Mar 10, 2025

Clearmind Medicine Inc. Announces Patent Publication for Innovative Combination Therapy Targeting Cocaine Addiction - Nasdaq

Mar 10, 2025
pulisher
Mar 02, 2025

SciSparc Ltd. announced that it expects to receive $2 million in funding from Yorkville Advisors Global LP - Marketscreener.com

Mar 02, 2025
pulisher
Feb 25, 2025

Obesity Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Feb 25, 2025
pulisher
Feb 25, 2025

Head-To-Head Comparison: Clearmind Medicine (CMND) versus The Competition - Defense World

Feb 25, 2025
pulisher
Feb 07, 2025

Clearmind Medicine (NASDAQ:CMND) Stock Quotes, Forecast and News Summary - Benzinga

Feb 07, 2025
pulisher
Feb 04, 2025

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

SciSparc and Clearmind’s Patent Publication Marks Progress in Binge Behavior Treatment - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

Clearmind Medicine Secures Patent For Psychedelic Combination Therapy In Mexico - Nasdaq

Feb 04, 2025
pulisher
Feb 04, 2025

SciSparc Ltd.-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico - Marketscreener.com

Feb 04, 2025
pulisher
Feb 04, 2025

SciSparc Ltd. and Clearmind Medicine Inc. Collaborate on Patent Application for Innovative Combination Therapy to Address Binge Behaviors - Nasdaq

Feb 04, 2025
pulisher
Feb 04, 2025

Game-Changing Addiction Treatment Patent: SciSparc-Clearmind's MDMA Breakthrough Expands Global Reach - StockTitan

Feb 04, 2025
pulisher
Feb 04, 2025

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico - The Manila Times

Feb 04, 2025
pulisher
Feb 04, 2025

Clearmind Medicine Inc. Announces Patent Publication for Innovative Combination Therapy Targeting Binge Behavior - Nasdaq

Feb 04, 2025
pulisher
Feb 04, 2025

Novel Psychedelic-Based Therapy Gets Patent Green Light: Targets Multiple Addictions - StockTitan

Feb 04, 2025
pulisher
Jan 22, 2025

EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds - MSN

Jan 22, 2025
pulisher
Jan 16, 2025

SciSparc Ltd. Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing - Marketscreener.com

Jan 16, 2025
pulisher
Jan 11, 2025

Clearmind Medicine (NASDAQ:CMND) Trading Up 6.3% – Still a Buy? - Defense World

Jan 11, 2025
pulisher
Jan 08, 2025

SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com

Jan 08, 2025
pulisher
Jan 07, 2025

Clearmind Medicine Announces Shareholders Meeting Results - The Manila Times

Jan 07, 2025
pulisher
Jan 07, 2025

Scisparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment - Marketscreener.com

Jan 07, 2025
pulisher
Jan 07, 2025

SciSparc and Clearmind Medicine Advance with European Patent Application for Psychedelic Binge Behavior Treatment - TipRanks

Jan 07, 2025
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):